Синдром длительного COVID-19 и эндотелиопатия: патофизиологические механизмы и терапевтические стратегии
- Авторы: Адашева Т.В.1, Саморукова Е.И.1, Губернаторова Е.Е.1, Лобанова Е.Г.1, Горулева Е.И.2
-
Учреждения:
- ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России
- ЧУОО ВО «Московский медицинский университет "Реавиз"»
- Выпуск: Том 8, № 3 (2022)
- Страницы: 101-108
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2412-4036/article/view/288940
- DOI: https://doi.org/10.18565/therapy.2022.3.101-108
- ID: 288940
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Ключевые слова
Полный текст
Об авторах
Татьяна Владимировна Адашева
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России
Email: adashtv@mail.ru
д.м.н., профессор, профессор кафедры поликлинической терапии
Елена Ивановна Саморукова
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России
Email: wlrad@bk.ru
к.м.н., ассистент кафедры поликлинической терапии
Екатерина Евгеньевна Губернаторова
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России
Email: creativone@list.ru
к.м.н., ассистент кафедры поликлинической терапии
Елена Георгиевна Лобанова
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России
Email: e.g.lobanova@mail.ru
д.м.н., профессор кафедры фармакологии
Екатерина Игоревна Горулева
ЧУОО ВО «Московский медицинский университет "Реавиз"»
Email: ekaterina.gorulyova@gmail.com
к.м.н., доцент кафедры внутренних болезней
Список литературы
- Daniel Ayoubkhani, Kamlesh Khunti, Vahe Nafilyan, Thomas Maddox, Ben Humberstone, Sir Ian Diamond, Amitava Banerjee Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study doi: https://doi.org/10.1101/2021.01.15.21249885
- Yan Xie, Evan, Benjamin Bowe and Ziyad Al-Aly. Long-term cardiovascular outcomes of COVID-19. Nature Medicine / www.nature.com/naturemedicine. 07 February 2022. https://doi.org/10.1038/s41591-022-01689-3.
- Varga Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417-1418 (2020)
- Akwii R.G., Sajib M.S., Zahra F.T. & Mikelis C.M. Role of angiopoietin-2 in Vascular physiology and pathophysiology. Cells 8, 471 (2019).
- Scholz A., Plate K.H. & Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann. N. Y. Acad. Sci. 1347, 45-51 (2015).
- Didion S.P. Cellular and oxidative mechanisms associated with interleukin-6 signaling in the vasculature. Int J. Mol. Sci. 18, 2563 (2017).
- De Mello W.C. Chemical communication between heart cells is disrupted by intracellular renin and angiotensin II: implications for heart development and disease. Front. Endocrinol. 6, 72 (2015).
- Figueroa C.D. et al. Kinin B1 receptor regulates interactions between neutrophils and endothelial cells by modulating the levels of Mac-1, LFA-1 and intercellular adhesion molecule-1. Innate Immun. 21, 289-304 (2015).
- Lopatko Fagerstrom I. et al. Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation. 2020. EBioMedicine 47
- Pennathur S. & Heinecke J.W. Oxidative stress and endothelial dysfunction in vascular disease. Curr. Diabetes Rep. 7, 257-264 (2007).
- Di A., Mehta D. & Malik A.B. ROS-activated calcium signaling mechanisms regulating endothelial barrier function. Cell Calcium 60, 163-171 (2016).
- Scioli M.G. et al. Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: potential diagnostic biomarkers and therapeutic targets. J. Clin. Med. 9, 1995 (2020).
- Violi F. et al. Nox2 activation in covid-19. Redox Biol. 36, 101655 (2020).,
- Didion S.P. Cellular and oxidative mechanisms associated with interleukin-6 signaling in the vasculature. Int J. Mol. Sci. 18, 2563 (2017).
- Noris M., Benigni A. & Remuzzi G. The case of complement activation in COVID- 19 multiorgan impact. Kidney Int. 98, 314-322 (2020).
- Cugno M. et al. Complement activation in patients with COVID-19: A novel therapeutic target. J. Allergy Clin. Immunol. 146, 215-217 (2020).
- Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal. Infect. 50, 332-334 (2020).
- Luo X. et al. Prognostic value of C-reactive protein in patients with COVID-19. Clin. Infect. Dis. 71, 2174-2179 (2020).
- Devaraj S., Kumaresan P.R. & Jialal I. C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction. Clin. Chem. 57, 1757-1761 (2011).
- Verma S. et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106, 913-919 (2002).
- Verma S. et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105, 1890-1896 (2002).
- Ohishi M.; Yamamoto K.; Rakugi H. Angiotensin (1-7) and other angiotensin peptides. Curr. Pharm. Des. 2013, 19, 3060-3064.
- Teuwen L.A.; Geldhof V.; Pasut A.; Carmeliet P. COVID-19: The vasculature unleashed. Nat. Rev. Immunol 2020, 20, 389-391.
- Pons S.; Fodil S.; Azoulay E.; Zafrani L. The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit. Care 2020, 24, 353.
- Okada H.; Yoshida S.; Hara A.; Ogura S.; Tomita H. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection. Microcirculation 2020, e12654.
- Uchimido R.; Schmidt E.P.; Shapiro N.I. The glycocalyx: A novel diagnostic and therapeutic target in sepsis. Crit. Care 2019, 23, 16.
- Yamaoka-Tojo М. Vascular Endothelial Glycocalyx Damage in COVID-19 Int. J. Mol. Sci. 2020, 21, 9712; doi: 10.3390/ijms21249712
- Yamaoka-Tojo M. A note on systemic inflammatory-reactive microvascular endotheliopathy (SIRME): Prevention of cardiovascular disease and COVID-19. JJCDP 2020, 55, 1-14.].
- Butler P.J.; Bhatnagar A. Mechanobiology of the abluminal glycocalyx. Biorheology 2019, 56, 101-112.
- Betteridge K.B.; Arkill K.P.; Neal C.R.; Harper S.J.; Foster R.R.; Satchell S.C.; Bates D.O.; Salmon A.H.J. Sialic acids regulate microvessel permeability, revealed by novel in vivo studies of endothelial glycocalyx structure and function. J. Physiol. 2017, 595, 5015-5035. [CrossRef]
- Butler M.J.; Ramnath R.; Kadoya H.; Desposito D.; Riquier-Brison A.; Ferguson J.K.; Onions K.L.; Ogier A.S.; ElHegni H.; Coward R.J. et al. Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx. Kidney Int. 2019, 95, 94-107.
- Curry F.E. Layer upon layer: The functional consequences of disrupting the glycocalyx-endothelial barrier in vivo and in vitro. Cardiovasc. Res. 2017, 113, 559-561
- Thi M.M.; Tarbell J.M.; Weinbaum S.; Spray D.C. The role of the glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: A "bumper-car" model. Proc. Natl. Acad. Sci. USA 2004, 101, 16483-16488.
- Bar A.; Targosz-Korecka M.; Suraj J.; Proniewski B.; Jasztal A.; Marczyk B.; Sternak M.; Przybylo M.; Kurpinska A.;Walczak M. et al. Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice. J. Am. Heart Assoc. 2019, 8, e011171. ].
- Tang T.H.; Alonso S.; Ng L.F.; Thein T.L.; Pang V.J.; Leo Y.S.; Lye D.C.; Yeo T.W. Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity. Sci. Rep. 2017, 7, 46191.
- Chelazzi C., Villa G., Mancinelli P., De Gaudio A.R., Adembri C. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care 2015;19:26.
- Hideshi Okada 1, Shozo Yoshida, Akira Hara, Shinji Ogura, Hiroyuki Tomita. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection PULMONARY AND CRITICAL CARE PERSPECTIVES. doi:10.1111/ MICC.12654
- Helen Fogarty 1, Liam Townsend 2, 3, Hannah Morrin1 Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome. Journal of Thrombosis and Haemostasis. 10 August 2021. doi: 10.1111/jth.15490
- Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 15, 22.02.2022.
- Hasan K. Siddiqi, Peter Libby, Paul M. Ridker. COVID-19 - A vascular disease. Trends in Cardiovascular Medicine 31 (2021) 1-5 https://doi.org/10.1016/j.tcm.2020.10.005
- Broekhuizen L.N., Lemkes B.A., Mooij H.L. et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia. 2010; 53 (12): 2646-2655.
- V. Masola et al. Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects International angiology: a journal of the International Union of Angiology ■ June 2014
- F. Mannello D. Ligi M. canale and J. Raffetto, "Sulodexide Down-Regulates the Release of Cytokines, Chemokines, and Leukocyte Colony Stimulating Factors from Human Macrophages: Role of Glycosaminoglycans in Inflammatory Pathways of Chronic Venous," Current Vascular Pharmacology, vol. 12, no. 1, pp. 173-185, 2014
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Epub 2020 Jan 30
- Management of chronic venous disorders of the lower limbs. Guidelines
- According to Scientific Evidence. Part II. journal of the International Union of Angiology ■ March 2020 doi: 10.23736/S0392-9590.20.04388-6
- Alejandro J. Gonzalez-Ochoa, Joseph D. Raffetto, Ana G. Hernandez, Nestor Zavala, Obed Gutierrez, Arturo Vargas, Jorge Loustaunau, Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial, Thromb Haemost. 2021 Mar 7. doi: 10.1055/a-1414-5216